Cargando…
SOX2 Mediates Metabolic Reprogramming of Prostate Cancer Cells
New strategies are needed to predict and overcome metastatic progression and therapy resistance in prostate cancer. One potential clinical target is the stem cell transcription factor SOX2, which has a critical role in prostate development and cancer. We thus investigated the impact of SOX2 expressi...
Autores principales: | de Wet, Larischa, Williams, Anthony, Gillard, Marc, Kregel, Steven, Lamperis, Sophia, Gutgesell, Lisa C., Vellky, Jordan E., Brown, Ryan, Conger, Kelly, Paner, Gladell P., Wang, Heng, Platz, Elizabeth E., De Marzo, Angelo M., Mu, Ping, Coloff, Jonathan L., Szmulewitz, Russell Z., Vander Griend, Donald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858874/ https://www.ncbi.nlm.nih.gov/pubmed/35067686 http://dx.doi.org/10.1038/s41388-021-02157-x |
Ejemplares similares
-
Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer
por: Kregel, Steven, et al.
Publicado: (2013) -
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer
por: Kregel, Steven, et al.
Publicado: (2016) -
Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer – A Case Report
por: VanderWeele, David J., et al.
Publicado: (2015) -
Circulating tumor cells capture disease evolution in advanced prostate cancer
por: Lack, Justin, et al.
Publicado: (2017) -
MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans
por: VanOpstall, Calvin, et al.
Publicado: (2020)